The most common are gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain and constipation
What Is the New Black Box Warning on Ozempic
London: Patients using Novo Nordisk's wildly popular weigh-loss drug Wegovy and its similar medicines for type 2 diabetes may be at increased risk for a sight-threatening eye condition, according to data from a study published on Wednesday
On August 18, the Food and Drug Administration (FDA) granted accelerated approval of Wegovy (semaglutide), in conjunction with a reduced-calorie diet and exercise, for people with metabolic dysfunction-associated steatohepatitis (MASH) who have moderate to advanced liver fibrosis but have not yet developed cirrhosis
One way it does that is by shifting these hormones in a direction that promotes hunger, Dr